Temofan 250 Capsule: Temozolomide 250 mg - Specialized High-Dose Neuro-Oncology Care

Mechanism of Action: BBB-Penetrating Alkylating Agent for Brain Tumors

Critical Role in Concurrent and Adjuvant Therapy for Newly Diagnosed Glioblastoma (GBM)

High-Dose Advantage: 250 mg Capsule for Optimal Dosing and Patient Convenience

Important: Dosing Schedule, Drug-Drug Interactions, and Myelosuppression Monitoring
Secure Your Monopoly: Temofan 250 PCD Pharma Franchise in High-Value Neuro-Oncology

Temofan 250 Capsule

Composition : Temozolomide IP 250 mg Capsule

Dosage Form : Capsule

Packaging Type : in a Bottle

Packaging : 5 Capsule

Price : ₹0/-

Please Contact For Best Price

Temofan 250 Capsule (Temozolomide IP ) is the largest-dose presentation of this highly specialized, oral cytotoxic chemotherapy, an Alkylating Agent critical for treating the aggressive brain tumor, Glioblastoma Multiforme ().

Mechanism and Impact:Temozolomide acts as a prodrug that rapidly crosses the Blood-Brain Barrier () before converting to its active form, MTIC, which methylates DNA and induces cell death in tumor cells. The Capsule size is vital for achieving the high initial doses required during the concurrent phase with radiation, as well as simplifying the daily pill burden for patients during the long-term adjuvant treatment cycles.

Key Therapeutic Uses:

  • : Used concurrently with radiation therapy and subsequently as adjuvant monotherapy.

  • Anaplastic Astrocytoma: Used for patients who have relapsed or progressed.

This high-dose product offers significant commercial value. We offer an exclusive PCD Pharma Franchise opportunity for Temofan 250 Capsule, allowing partners to secure a premium position in the neuro-oncology market.

Read More

About the Product

Temofan 250 Capsule (Temozolomide IP ) is the largest-dose presentation of this highly specialized, oral cytotoxic chemotherapy, an Alkylating Agent critical for treating the aggressive brain tumor, Glioblastoma Multiforme ().

Mechanism and Impact:Temozolomide acts as a prodrug that rapidly crosses the Blood-Brain Barrier () before converting to its active form, MTIC, which methylates DNA and induces cell death in tumor cells. The Capsule size is vital for achieving the high initial doses required during the concurrent phase with radiation, as well as simplifying the daily pill burden for patients during the long-term adjuvant treatment cycles.

Key Therapeutic Uses:

  • : Used concurrently with radiation therapy and subsequently as adjuvant monotherapy.

  • Anaplastic Astrocytoma: Used for patients who have relapsed or progressed.

This high-dose product offers significant commercial value. We offer an exclusive PCD Pharma Franchise opportunity for Temofan 250 Capsule, allowing partners to secure a premium position in the neuro-oncology market.

Common side effects may include low blood pressure, dizziness, cough, high potassium levels, and kidney problems. Rare but serious side effects include swelling of the face or throat (angioedema), severe allergic reactions, or kidney failure. Seek medical attention immediately if you experience severe swelling, difficulty breathing, or sudden swelling.

Used to treat chronic heart failure with reduced ejection fraction and to lower the risk of heart-related complications.

Take this medicine exactly as prescribed by your doctor. Do not stop the medication without consulting your healthcare provider. Regular monitoring of blood pressure, kidney function, and potassium levels is important while on this medication. Inform your doctor if you are pregnant, breastfeeding, have kidney or liver problems, or are taking other medications. Avoid using potassium supplements or salt substitutes unless advised.

Store in a cool, dry place below 30°C, protected from moisture and sunlight. Keep out of reach of children.

Get in Touch